China BCT Pharmacy Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNBI research report →
Company
China BCT Pharmacy Group, Inc. , through its subsidiaries, operates as an integrated pharmaceutical company in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Retail Pharmacy, and Manufacturing Pharmacy.
- CEO
- Huitian Tang
- IPO
- 2010
- Employees
- 1,677
- HQ
- Liuzhou, CN
Price Chart
Valuation
- Market Cap
- $686.78K
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.15
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 20.13%
- Op Margin
- 12.15%
- Net Margin
- 8.70%
- ROE
- 16.79%
- ROIC
- 11.56%
Growth & Income
- Revenue
- $241.87M · -6.07%
- Net Income
- $21.05M · -32.51%
- EPS
- $0.42 · -41.67%
- Op Income
- $29.39M
- FCF YoY
- -66.52%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -3.86
- Avg Volume
- 47
Get TickerSpark's AI analysis on CNBI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CNBI Coverage
We haven't published any research on CNBI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CNBI Report →